.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078651

« Back to Dashboard
NDA 078651 describes ROCURONIUM BROMIDE, which is a drug marketed by Tamarang, Teva Pharms, Hospira, Fresenius Kabi Usa, Sagent Pharms, Sandoz, and Mylan Institutional, and is included in seven NDAs. It is available from eight suppliers. Additional details are available on the ROCURONIUM BROMIDE profile page.

The generic ingredient in ROCURONIUM BROMIDE is rocuronium bromide. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the rocuronium bromide profile page.

Summary for NDA: 078651

Tradename:
ROCURONIUM BROMIDE
Applicant:
Fresenius Kabi Usa
Ingredient:
rocuronium bromide
Patents:0

Pharmacology for NDA: 078651

Suppliers and Packaging for NDA: 078651

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION 078651 ANDA Fresenius Kabi USA, LLC 63323-426 63323-426-05 10 VIAL in 1 TRAY (63323-426-05) > 5 mL in 1 VIAL
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION 078651 ANDA Fresenius Kabi USA, LLC 63323-426 63323-426-10 10 VIAL in 1 TRAY (63323-426-10) > 10 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50MG/5ML (10MG/ML)
Approval Date:Dec 29, 2008TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength100MG/10ML (10MG/ML)
Approval Date:Dec 29, 2008TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc